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 Solid phase microextraction (SPME) has gained much popularity for in vivo applications 
recently. Thus far, there are two types of pre-equilibrium kinetic calibration that have been 
applied to in vivo SPME: on-fibre standardization and dominant pre-equilibrium desorption. Both 
of these techniques have their own advantages and disadvantages. To address the limitations 
presented by these two techniques, a third pre-equilibrium kinetic calibration method, the 
diffusion-based interface model, was investigated. The diffusion-based interface model had been 
successfully applied to air and water samples but was never utilized for in vivo SPME studies. 
For the first part of the research, on-fibre standardization, dominant pre-equilibrium desorption, 
and diffusion-based interface model were compared in terms of accuracy, precision, and 
experimental procedures, by using a flow-through system. These three kinetic calibrations were 
further validated by equilibrium SPME extraction and protein-plasma precipitation, a current 
state-of-the-art sampling method.  
 The potential of diffusion-based interface model was yet again demonstrated in the 
second part of the research project. This calibration method was applied to comparative 
pharmacokinetic studies of two drugs, fenoterol and methoxyfenoterol, on 5 rats. To provide a 
constant sampling rate as required for diffusion-based interface model, a SPME animal sampling 
autosampler, AccuSampler®, was utilized. It custom-written program allowed the entire SPME 
sampling procedure excluding insertion and removal of SPME probes to be automated. 
Furthermore, to validate the results obtained by SPME, the AccuSampler® was programmed to 
withdraw blood after each SPME sampling time point for conventional method analysis using 
protein-plasma precipitation. The well correlated data obtained by SPME sampling and the 
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conventional method illustrated the potential of diffusion-based interface model as an excellent 
choice for future in vivo SPME applications.   
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Chapter 1:   Introduction 
 
 In vivo studies have always had importance in biological and chemical processes 
for drug development. Since in vivo studies are conducted within a living organism, 
results obtained for therapeutic and toxic effects of a drug are more relevant in 
comparison with in vitro studies. There are many factors to consider when selecting an in 
vivo sampling technique. These include sensitivity, accuracy, and precision of the overall 
method.  
 Solid phase microextraction (SPME), which was invented by Dr. Janusz 
Pawliszyn in the late 1980s, has recently gained much popularity for in vivo studies due 
to its advantage of integrating the sampling and sample preparation procedures. Owing to 
the minimal number of experimental steps required that prevent significant error such as 
sample loss and operation error, high sensitivity, accuracy, and precision are achievable 
using SPME.  
 
 
1.1 Principles of Solid Phase Microextraction (SPME) 
 
  
There are three main experimental steps for analysis with SPME: extraction, 
desorption, and instrumental analysis [1]. During extraction, analyte in the sample 
partitions into the extraction phase of the SPME fibre, and further partitions into the 
desorption solvent during desorption. Subsequently, the desorption solvent is injected 
into the analytical instrument for separation and quantitation [1].  
 At the initial stage of extraction, the amount extracted increases linearly with 
time. However, later on, extraction reaches equilibrium. In other words, equilibrium is 
reached between the amount extracted on the fibre and what is left in the sample matrix.  
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The time at which equilibrium occurs is termed the equilibration time. In biological 
studies with SPME, sampling often occurs with matrices such as plasma or whole blood, 
which contain biomolecules such as red blood cells and proteins [1]. At the equilibration 
time, the free concentration of the analyte and the concentration of the bound analyte on 
the biomolecules are also at equilibrium with each other (Figure 1). In other words, the 
amount extracted is at its maximum during equilibrium and a longer extraction time has 
no effect on this amount [2].    
 





Figure 1: Schematic representation of direct fibre extraction [1]. Equilibrium of the free 
concentration of the analyte occurs between the extraction phase on the fiber 
and in the sample matrix as well as between free concentration of the analyte in 
the sample matrix and the bound analyte on the proteins. 
 
 
The amount extracted by SPME at equilibrium can be calculated as follows:  
 
        n = Kfs ·Vf ·             (1) 










where ne is the amount extracted, Kfs is the distribution constant of the extraction phase 
and sample, Vf is the volume of the extraction phase, Vs is the sample volume, and C0 is 
the initial concentration of the target analyte [1]. However, when the volume of the 
sample matrix is very large, so that Kfs ·Vf << Vs, the amount extracted n can be calculated 
as follows:      
                                                                                                                                     (2) 
 
The simplification from equation 1 to equation 2 illustrates the advantage of SPME for on 
site or in vivo analysis; a defined volume is unnecessary for direct exposure of the probe 
to the sample matrix [1].  
 
 
1.2 In Vivo SPME 
 
  
 Traditional in vivo studies on small animals may require sacrificing animals due 
to the removal of blood samples. For such in vivo analysis, SPME offers two main 
advantages. First, since blood withdrawal is not necessary and the circulating blood 
volume does not change, the number of animals used is minimized. Second, only a 
minimal disturbance to the chemical balance of the system occurs since substance 
depletion is negligible as only a small amount of the free analyte is extracted [3]. 
Therefore, since only a small amount of analyte is extracted and the circulating blood 
volume is preserved, more data points can be obtained per animal and thus the inter-
animal variances are decreased and accurate results are achieved. 
 Early in vivo studies with SPME measuring venous blood concentrations of a 
substance involved sampling in the vein directly where a catheter was placed in a 
ffse VKCn 0
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peripheral vein and sealed with a PRN adapter [4]. The SPME probe was loaded into a 
needle that was used to pierce the PRN adapter. Subsequently, the probe slid into the 
catheter, exposing the extraction phase, and the needle was withdrawn [4]. However, this 
technique was rather cumbersome. Blood exposure and blood leaking from the catheter 
during the insertion and removal of the probes were inevitable. To overcome these 
obstacles, a new type of SPME device was invented that prevents any leaking of blood 





Figure 2: A special SPME device for in vivo extraction [5] 
 
 
The SPME device consists of a thin flexible wire coated with an extraction phase housed 
in a hypodermic needle [5]. The assembly including the wire and needle is sealed with 
silicone glue. During extraction, the reinforcement tube is depressed to allow the 
exposure of the extraction phase into the flowing blood of the vein [5].  
This new SPME device simplifies extraction procedures and sampling can be 
done much more efficiently. Its usefulness has been demonstrated in applications such as 
monitoring intravenous concentrations of drugs and metabolites in beagles and rats [6, 7], 




1.2.1 Applications Of In Vivo SPME 
  In the study of the pharmacokinetics of diazepam by Lord et al. [4], the venous 
concentration of diazepam and its metabolites, oxazepam and nordiazepam, were 
monitored in three beagles following intravenous administration of diazepam and were 
compared with the profiles obtained with SPME by conventional analysis for validation. 





Figure 3: Pharmacokinetic profiles of A) diazepam B) oxazepam and C) nordiazepam 
from the average of three studies in three beagles after dosage with diazepam. 
The venous concentration was monitored over the course of 8 hours for the 3 
drugs. (n=6 for the last point and n=9 for all the other points). Diamonds 
represent SPME probe and squares represent conventional method [4]. 
 
 
In the pharmacokinetic profile of diazepam, a rapid distribution phase followed by a less 
rapid decay in concentration occurred over the period of study. The rate of metabolism 
from diazepam to nordiazepam was fast since a high concentration of nordiazepam was 
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detected at early time points (Figure 3C) [4]. For oxazepam, the rate of formation and the 
rate of elimination was the same up to 1.5 hours of post dosage of diazepam.   
 The advantage of SPME is seen more prominent when pharmacokinetic studies 
are performed in smaller animals such as rodents (Figure 4) [7]. 
 
 
Figure 4: Schematic diagram of SPME sampling with rodents. The lower tube was 
connected to the carotid artery catheter and the upper tube was either 
recirculated to the carotid artery catheter or was connected to a syringe [7] 
  
 
The limited blood volume in small animals will result in sacrificing animals when in vivo 
sampling requires withdrawal of large volumes of blood. A recent article published by 
Musteata et al. had demonstrated the success of pharmacokinetic studies of diazepam and 
its metabolites in rats using SPME [7]. The results were found to correlate well with the 





 The feasibility of in vivo SPME was demonstrated by Zhou et al. [8] in the field 
sampling of pharmaceuticals in fish muscles. In the study, wild fishes were collected 
from different river locations with variability in municipal wastewater effluent. The 
fishes were sampled by SPME and the amount extracted was compared linearly with the 
waterborne concentrations of pharmaceuticals understudy [8].   
 
 
1.3 Calibration Procedures in SPME 
 
 
 Successful usage of SPME depends on the selection of calibration method. 
Equilibrium extraction remains an attractive option because during in vivo SPME testing 
in a conscious animal, the blood flow rate within the catheterized blood vessel, which is 
analogous to the speed of agitation, is uncontrollable. However, the amount of analyte 
extracted at equilibrium is independent of flow rate, so accurate and reliable quantitation 
can be achieved using equilibrium sampling [9].  
 Lord et al. performed the first in vivo SPME pharmacokinetic studies to measure 
the circulating concentration of diazepam and its metabolites in Beagle dogs using an 
extraction time of 30 minutes which was sufficient to establish equilibrium between the 
fibre and blood [4]. However, such a long sampling time limits temporal resolution 
because the determined concentration would be an average of the overall sampling time 
period and is feasible only when very thin coatings such as polypyrrole [4] are used. For 
some SPME fibres, however, equilibrium extraction is not practical, since equilibration 
takes too long [10]. In this case, the use of pre-equilibrium sampling strategy in 
combination with kinetic calibration is a better method of sampling [11-19]. 
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1.3.1 On-fibre Standardization 
 
Ai et al. has proposed a theoretical model based on a diffusion-controlled mass-
transfer process to describe the kinetic process of SPME both in the linear and 
equilibrium regime [11-12]. Using this model, Chen et al. demonstrated the isotropy of 
extraction and desorption processes and therefore proposed that the extraction process 
could be calibrated using the process of desorption of standard loaded on the fibre [13]. 
The isotropic relationship between extraction and desorption exists when the addition of 
the rate of extraction and rate of desorption is close to or equal to 1 and therefore can be 





Figure 5: Absorption time profiles for diazepam ( ), nordiazepam ( ), and oxazepam (Δ), 
and desorption time profiles for their deuterated analogues, diazepam-d5 ( ), 








                 
              (3) 
 
 
where n is the amount of analyte extracted at time t, ne is the amount of analyte extracted  
at equilibrium or maximum extraction, q0 is the amount of standard pre-loaded on the 
extraction phase, and Q is the amount of standard left on the extraction phase after 
sampling time t. Therefore, by sampling with a pre-loaded fibre, the amount desorbed 
into the sample matrix can calibrate the extracted analyte [13].  
Rate of desorption of the standard can be described by the mathematical equation 
as follows:  
 
                  (4) 
 
 
where a is a time constant that is dependent on the volume of fibre coating and sample 
matrix, mass transfer coefficients, distribution coefficients and the fibre’s surface area 
[13]. Extraction of analytes onto the extraction phase can be described as follows [13]: 
                                       (5) 
 
 
When isotropy exists between extraction and desorption, that is, when the two processes 
have the same time constant, equation 4 and 5 can be combined to equation 3 [14]. The 
calculated value for ne can subsequently be used to calculate the free concentration of the 

















standardization method for in vivo studies compensates for matrix effects and the effects 
of agitation or blood flow rate when sampling from an animal [7, 15]. 
 
1.3.2 Dominant Pre-equilibrium Desorption  
On-fibre standardization has been successfully applied to in vivo studies [7, 15] 
and other areas such as environmental monitoring [16] and food [14]. However, for this 
standardization technique, a standard is required for pre-loading onto the fibre. These 
standards, usually radioactive compounds or deuterated analogues of the analyte, are 
relatively expensive and the availability is limited. Moreover, addition of standard into 
the sample matrix can possibly have a negative impact on the system under investigation. 
Therefore, a standard-free calibration method was introduced by Zhou et al [18]. Similar 
to on-fibre standardization, dominant pre-equilibrium desorption, uses the isotropic 
relationship between the amount extracted and amount desorbed for calibration.  
 For dominant pre-equilibrium desorption, it was found that the rate of desorption 
is constant when the pre-loaded amount is four-fold higher than the potential extracted 
amount from the sample matrix. When this requirement is fulfilled, desorption becomes 
dominant and extraction by the same fibre is negligible [18]. Another prominent factor to 
consider in this calibration method is the distance between the desorption fibre and the 
extraction fibre. Because the preloaded standard is the same as the extracted analyte, 
these fibres must be kept apart from each other in order to prevent them from affecting 
each other but not too far so that the matrices between desorption and extraction are 
different [18].    
 Pre-equilibrium desorption was applied to a jade plant (Crassula ovata) for 
pesticide sampling.  Figure 6 illustrates the locations where the desorption and extraction 
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fibres were inserted. The desorption fibres were previously pre-loaded with the pesticides 





Figure 6: Application of pre-dominant desorption on jade plants. The locations for SPME 
absorption and desorption are illustrated [18] 
  
 
In addition to jade plants, this technique has been applied to study pharmaceutical 
accumulation in wild fish using separate animals for desorption and extraction [8]. 
 
1.3.3 Diffusion-based interface Model 
 Although dominant pre-equilibrium desorption does not require other standards, 
this calibration method may be too costly because different fibres are needed for both 
extraction and desorption. In addition, a different animal may be used for calibration if 
the sampling area of the animal is too small to fit both an extraction and a desorption 
fibre as was the case when sampling muscle of wild fish where one fish was used for 
extraction and another for desorption [8].  
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To address the limitations of dominant pre-equilibrium desorption, another 
standard-free pre-equilibrium calibration method, the diffusion-based-interface 
calibration model was investigated for in vivo SPME studies [19-22]. Similar to dominant 
pre-equilibrium desorption, the diffusion-based-interface model uses the analyte itself to 
calibrate the amount extracted. However, unlike dominant pre-equilibrium desorption, 
this method requires fewer SPME fibres and the size of sampling area is not of great 
concern. 
 Diffusion-based interface model calibration is based primarily on the principle of 
analyte diffusion from the sample matrix to the fibre [19]. First, the analyte travels from 
the sample matrix to the surface of the fibre. Depending on the types of fibre used and 
thus the mode of extraction, the analyte will partition into the bulk of the polymer, in the 
case of absorption extraction, or adsorb onto the binding sites available on the surface of 
the coating, in the case of adsorption extraction. In the mass transfer process, the analyte 
must travel through the boundary layer, the layer between the bulk of the sample and the 
fibre surface (Figure 7), to the surface of the fibre [19]. When a fibre is submerged into 
the sample matrix for extraction, the fluid that is touching the surface of the fibre is 
stationary. As the distance from the fibre surface increases, the fluid movement increases 








 During pre-equilibrium extraction, the concentration gradient of the analyte across 
the boundary layer is high since the concentration of analyte in the sorbent (Csorbent) is 
practically zero [19]. Therefore, diffusion of the analyte occurs from high concentration, 
the bulk sample, to low concentration, the sorbent. This allows the rate of extraction to be 
correlated linearly to the concentration of the analyte in the sample and calibration can be 
performed according to the extraction rate [19]. The concentration of the bulk sample can 
be determined as follows: 
 









where b is the outside radius of the fibre coating, δ is thickness of boundary layer, DL is 
the diffusion coefficient of the analyte in the sample matrix, and L is the length of the 
fibre [19].  The thickness of boundary layer, δ, can be calculated as follows: 
                                                                   (7) 
 
where Re is the Reynolds number and Sc is the Schmidt number. 
Using the amount extracted and the known concentration in the sample, the calibration 
constant can be determined by rearranging equation (6) and defining the calibration 
constant as follows: 
 
 Calibration Constant= 
 
Once the calibration constant is determined, it can be applied to samples with unknown 
concentration.  
For diffusion-based interface model calibration, it is important to note that with a 
prolonged extraction time or extraction at equilibrium, Csorbent cannot be assumed as zero 
and therefore diffusion-based calibration cannot be applied. In addition, since extraction 
is based on the concentration gradient across the boundary layer, the size of the boundary 
layer must be kept constant during sampling for an accurate calibration. Since speed of 
agitation has a direct effect on the thickness of the boundary layer, a control of the 
sampling speed during extraction is required.  
Diffusion-based interface calibration is convenient as it uses the analyte of 
interest for calibration. In some cases where the target analyte is well researched, the 







coating, the extraction time, and diffusion coefficient for the analyte [20]. This 
calibration method, therefore, offers an attractive alternative to other pre-equilibrium 
calibration methods.  
 
 
1.4 Research Proposal  
 
 
The utility of in vivo SPME sampling has been demonstrated using animals of 
different sizes with different calibration methods.  On-fibre standardization has been 
applied successfully on beagles and rats in studying the pharmacokinetics of diazepam 
and its metabolites. However, this method requires radioactive or deuterated standards 
which may be difficult to find or harmful to the investigated system. To overcome this 
problem, a novel standard-free calibration technique, dominant pre-equilibrium 
desorption, was introduced. Nevertheless, this method has several shortcomings; first, it 
requires more fibres than other calibration methods since different sets of fibre for 
extraction and pre-loading for desorption are needed. This not only increases the cost of 
the experiment, but also decreases the precision of the data due to fibre variability. 
Second, when in vivo studies are performed on animals, two different animals may be 
required if the sampling area is too small to fit both an extraction fibre and a pre-loaded 
fibre.  
Due to these reasons, the diffusion-based interface model, another standard-free 
calibration method, was investigated. In this method, the bulk concentration is 
determined by the calibration constant, which can be determined experimentally or 
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theoretically. In this research, three calibration methods were compared, using a flow-
through system, and validated by SPME equilibrium extraction and plasma-protein 
precipitation. All methods were compared in terms of accuracy, precision, and ease of 
operation. The best calibration method, the diffusion-based interface model, was selected 
and applied in pharmacokinetic studies of fenoterol and methoxyfenoterol in rats. 
AccuSampler®, an automated in vivo sampling system, was used to provide a constant 
sampling rate as required for the diffusion-based interface method. All SPME sampling 
procedures except for the insertion and removal of the SPME probe were automated with 
the custom-written program installed in AccuSampler®. All SPME data obtained were 





Chapter 2:  In vivo SPME calibration method comparison: on-fibre standardization, 







 SPME has recently gained ground for in vivo studies relying on direct extraction of 
analytes of interest from a living system. However, success of applying SPME is greatly 
dependent on the selection of the calibration method. In this research, three in vivo SPME 
calibration methods, on-fibre standardization, dominant pre-equilibrium desorption, and 
diffusion-based interface model, were compared in terms of precision, accuracy, and ease of 
experimental procedures using a flow-through system. In addition, these calibration methods 
were further validated using SPME equilibrium extraction and a conventional method that 
involved protein precipitation. The comparison was performed using fenoterol as the analyte of 
interest and liquid chromatography (LC)-tandem mass spectrometry (MS) was used for the 
analysis. All three methods compared well with both the equilibrium extraction and the 
conventional method in terms of accuracy. In terms of precision, diffusion-based interface model 
had the best precision of 9-14% RSD in whole blood, and RSD of 9-15% in phosphate buffered 
saline (PBS). Dominant pre-equilibrium desorption had the poorest precision of 20-28% RSD in 
whole blood, and a RSD of 26-30% in PBS. The poorer precision observed for the dominant pre-
equilibrium desorption method can be explained by the need to use more fibres in comparison to 
the other two calibration methods. In terms of ease of experimental procedures, the diffusion-
based interface model was the simplest, as it did not require procedures such as fibre loading. 
This research suggests the potential use of diffusion-based interface model as the best calibration 
method for future in vivo SPME studies.    
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2.2 Materials and methods 
 
2.2.1 Materials 
 (R,R)-Fenoterol and (R,R)-methoxyfenoterol were obtained from National Institute of 
Health (Baltimore, MD, US). Pseudoephedrine, ammonium acetate and silicone oil were 
purchased from Sigma-Aldrich (St. Louis, MO, US). High performance liquid chromatography 
(HPLC) grade acetonitrile (ACN) and methanol (MeOH) were purchased from Fisher Scientific 
(Fair Lawn, NJ, US). Fresh rat whole blood (sterile, with sodium heparin as anticoagulant) and 
plasma were purchased from Lampire Biological Laboratories Inc. (Pipersville, PA, US). Rat 
whole blood was maintained at 4
0
C for a maximum of 1 week and plasma was kept frozen at -
20
0
C until use. Deionized water was obtained from a Barnstead/Thermodyne Nano-pure ultrapure 
water system (Dubuque, IA, US).      
 
2.2.2 LC-MS/MS Assay 
 For analysis of fenoterol and methoxyfenoterol, a Shimadzu (Kyoto, Japan) 10AVP LC 
consisting of a system controller and dual binary pumps, a CTC-PAL autosampler, and MDS 
Sciex API 3000 tandem MS were used. The MS system was operated in the electrospray 
ionization positive ion mode with selected reaction monitoring (SRM). Methoxyfenoterol was 
monitored using SRM transition of m/z 318.2→121.1, fenoterol was monitored at m/z 
304.3→107.1, and pseudoephedrine, the internal standard, was monitored at m/z 165.8→148.2. 
The optimum settings for MS parameters were obtained using direct infusion of 1 μg/mL 
standard solution. The source temperature was set to 500
0
C, ionspray voltage 4500 V, collision 
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activated dissociation (CAD) gas was 10, the nebulizer gas was 15, and the curtain gas was 10.  












Methoxyfenoterol 50 70 7 35 15 
Fenoterol 17 60 13 33 10 
Pseudoephedrine 15 70 10 15 10 
 
Table 1: MS parameters for methoxyfenoterol, fenoterol and pseudoephedrine 
  
 The LC-MS method was modified from Kim et al. [1]. Atlantis HILIC Silica 3μm (2.1 
mm X 50 mm) (Waters, Milford, MA, US) column was used. Before the first injection, the 
column was pre-conditioned for 1 hour with mobile phase B, which consisted of 
acetonitrile:ammonium acetate (pH unadjusted, 10 mM) (95:5, v/v). Mobile phase A was 
acetonitrile:ammonium acetate (pH unadjusted, 10 mM) (50:50, v/v). The flow rate was 0.5 
mL/min throughout the entire run time of 7 minutes. To avoid any contamination in the MS 
detector, the first minute of effluent was diverted to waste using Waters switching valve. The 

















Table 2: The LC gradient for fenoterol and methoxyfenoterol analysis 
 
The data collected were processed using the Analyst 1.4.1 software from MDS Sciex.   
 
2.2.3 In Vitro SPME Method Development 
 For SPME method development, both fenoterol and methoxyfenoterol were studied as 
methoxyfenoterol, although used only as an isotropic standard for on-fibre standardization in 
this chapter, pharmacokinetics study of methoxyfenoterol was performed in the following 
chapter.. 
  Selection of a commercially prototype fibre was based on highest extraction efficiency 
for the compounds of interest and lowest inter-fibre variations. Commercial prototype reverse 
phased amide (RPA) fibre, C18, and cyano (CN) type fibre were used for extraction under static 
conditions for 2 minutes in 100 ng/mL standard PBS buffer solution of fenoterol and 
methoxyfenoterol. RPA fibres were selected for subsequent experiments. A preconditioning 
method was selected based on the highest extraction efficiency. Fibres were either not 
preconditioned or preconditioned for various lengths of time in either desorption solvent of 
Time (mins) Events Parameter 
0.01 Event 2 
1.00 %B 100 
1.01 Event 0 
2.50 %B 50 
3.00 %B 50 
3.01 %B 100 
5.99 %B 100 
7.00 STOP 100 
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ACN:MeOH (80:20, v/v) or in 100% MeOH followed by 2 minutes extraction in static conditions 
in 100 ng/mL fenoterol in PBS buffer solution. 
 Desorption time was determined based on the lowest percentage of carryover. To 
determine the extraction time for subsequent in vivo studies, extractions were performed in 100 
ng/mL standard whole blood solution for either 2 or 4 minutes at 2 different pump flow rates of 
0.6 mL/min and 1.4 mL/min using a syringe pump (Kloehn Co. LTD, Las Vegas, Nevada, US). 
Extraction for 4 minutes at 1.4 mL/min was selected based on the highest sensitivity in 
comparison with other combinations. An extraction time profile was constructed using the flow 
rate of 1.4 mL/min and extraction in 100 ng/mL standard whole blood solution.  
 The stability of fenoterol and methoxyfenoterol was investigated. Fibres were desorbed 
after extraction times of 24, 36 and 72 hours. The extracted fibres were kept in a freezer and 
away from light until desorption. The linear ranges for SPME and plasma protein precipitation 
were determined from 10, 250, 500, 1000, 2000, 10000, to 20000 ng/mL. Each fibre was of 
single use. For extraction at higher concentrations, serial dilutions were made to the desorption 
solvent for SPME and supernatant for plasma protein precipitation method until the peak area 
was within the linear range of the instrument response. In addition, prior to desorption, the fibres 
were rinsed with nano-pure water for approximately 1 second to dissolve any impurities. The 
residual water on the fibre was blotted on Kimwipe tissue. 
 
2.2.4 Flow-through System  
 For the comparisons of the three kinetic calibration methods, a flow- through system was 




                         Tubing          Hot Plate 
                   PP   MR               SP                                             SPME Probe 
 Interface       Syringe 
 
                                                                                                                                                
 
Figure 8: A) Snapshot of the flow-through system with a peristaltic pump (PP) for providing a 
controlled linear velocity of fluid from the matrix reservoir (MR) to the tubing. A hole 
was drilled into the tubing where an interface was placed. On one side of the interface, 
a syringe or syringe pump (SP) was pierced into the septum of the interface where it 
provided the power for blood to flow through the interface. The SPME probe was 
pierced on the other side of the interface. A hotplate (HR) was used to control the 
temperature of the sample at 37-38
0




The peristaltic pump (VWR, cat # 57951-016, 4-600 mL/min) functioned as an artificial heart. 
The tubing functioned as an artificial vein and was selected based on three criteria: suitability for 
peristaltic pump usage, biocompatibility, and low or minimal extraction. Two types of tubing, 
Tygon S-50-HL and Tygon LFL were selected as they fulfilled the first two requirements. 
Subsequently, Tygon S-50-HL of I.D. X O.D.: 1/8 X 1/4 inch and wall thickness of 1/16 inch 
(VWR, cat # 63010-231) was selected as it extracted smaller amount of analytes compared to 
Tygon LFL. The peristaltic pump was set at a flow rate of 75 mL/min according to a previous 
experiment [2] but with an addition of a hot plate and a crystallizing dish on top with silicone oil 
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to maintain temperature at 38
0
C. Extractions were performed when the tubing was equilibrated at 
37-38
0
C. The setup was optimized using Beagle dog parameters as the pressure range in the 
circulation loop was within the same range as that expected in Beagle dog vein and incorporation 
of any external flow resistance was not necessary [2-3].   
 
 
2.2.5 Preparation of Calibration Standards   
 
 PBS buffer of pH 7.4 was prepared by dissolving 8g of NaCl, 0.2g of KCl, 1.44g of 
Na2HPO4, and 0.24g of KH2PO4 in water. To evaluate the accuracy of the calibration methods, 
extractions were performed in whole blood and PBS buffer with spiked fenoterol concentrations 
at 10, 5000, and 20,000 ng/mL which fall in the dynamic linear range determined previously. 
Prior to extraction, the blood was incubated with the spiked fenoterol for 24 hours. This allowed 
the drug to distribute evenly in the sample. The calibrated amount was compared with the true 
concentration in the sample. Three determinations were performed at each concentration level 
and using each kinetic calibration method in order to evaluate method precision. Equilibrium 
extraction and conventional method of plasma protein precipitation were performed for 
comparison with the three kinetic calibrations.  
 
2.2.6 On-fibre Standardization    
 For on-fibre standardization, methoxyfenoterol was used as the standard. To determine 
whether isotropic exists between fenoterol and methoxyfenoterol, the ratios of n/ne for both drugs 
were determined. For the determination of n, extraction was performed in 100 ng/mL whole 
blood using a flow rate of 1.4 mL/min. For ne, extraction was performed for 1 hour, the time it 
takes to reach equilibrium between whole blood and fibre according to the extraction time profile. 
Methoxyfenoterol, either 10 ng/mL or 1000 ng/mL in PBS buffer, was loaded overnight as the 
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standard on fibre. To obtain the value for q0, the fibres that were not used in subsequent 
extractions were desorbed in desorption solvent consisting of ACN and MeOH (80:20, v/v).  
 For extraction, the fibre loaded with methoxyfenoterol was pierced through one of the 
septa of the interface that was drilled through the tubing of the flow-through system. Meanwhile, 
a syringe was pierced through the other septa and used to manually push and pull the blood up to 
the interface at 1.4 mL/min. Extraction was performed for 4 minutes followed by desorption for 1 
hour in desorption solvent. For this calibration method, both Q and n were determined 
simultaneously using a single fibre.  
 
2.2.7 Dominant Pre-equilibrium Desorption 
 For dominant pre-equilibrium desorption, the preloaded amount must be at least 4-fold 
higher than the potential extracted amount from the sample matrix [4], so an experiment to 
determine the pre-loading concentration was first performed. Fibres were loaded with varying 
amounts of fenoterol using a series of different concentrations (5000, 10,000, 20,000, 50,000 
ng/mL) and were desorbed in desorption solvent to determine how much was loaded to obtain q0. 
Subsequently, 4 minute extractions were performed on the flow-through system using a syringe 
and non-loaded fibre to determine n. The concentrations of fenoterol were 10, 5000, and 20,000 
ng/mL. The amount extracted was compared with the amount loaded to decide on the 
concentration required for loading.   
 Due to the small area of the interface, extraction and desorption of the preloaded fibre 
were not performed simultaneously. The pre-loaded fibre was exposed to the flowing blood 
sample or PBS buffer of 10, 5000, and 20,000ng/mL of fenoterol for a 4 minutes desorption via a 
syringe again using the flow-through system. Subsequently, the desorbed pre-loaded fibre were 
desorbed in the desorption solvent for 1 hour to obtain Q.  
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2.2.8 Diffusion-based Interface Model 
 For diffusion-based calibration, the calibration constant was determined experimentally 
by performing five extractions in the flow-through system using 100 ng/mL fenoterol for 4 
minutes in both PBS buffer and whole blood. All extractions, both for the actual experiment and 
calibration constant, were performed with a syringe pump. To calculate the concentration of the 
sample, the experimentally determined calibration constant was applied according to equation 6. 
The calibration constant was also determined theoretically by calculations using equation 6 for 
comparison with the experimentally determined calibration constant. 
 
2.2.9 Equilibrium Extraction 
 For equilibrium extraction, each extraction was performed for 1 hour to reach equilibrium 
using the syringe pump and the flow-through system at 10, 5000, and 20,000 ng/mL in PBS 
buffer and whole blood followed by 1 hour desorption. A calibration curve was constructed from 
10 ng/mL – 20,000 ng/mL at the same extraction time to calculate the initial concentration in the 
sample. 
 
2.2.10 Conventional Blood Analysis 
 For validation purposes, 0.3mL blood was withdrawn using a syringe from the same 
interface where SPME probe was inserted. The blood sample was subsequently centrifuged 
(14,000 rpm, 5 min, 4
0
C) and plasma was isolated. A 0.08 mL portion of plasma was mixed with 
0.30 mL of HPLC grade ACN in conical centrifuge vials for protein precipitation. After vortex 
mixing (2400 rpm, 5 min) and centrifugation (14,000 rpm, 10 min, 4
0
C), 0.01 mL of the 
supernatant was transferred to a 0.1 mL insert (Supelco, Bellefonte, PA, US). 0.09 mL of 
desorption solvent for dilution and 0.01 mL of pseudoephedrine (50 ng/mL) as internal standard 
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to control for injection volume variation were added. The resulting solution was vortexed 
manually to ensure thorough mixing. External calibration was performed to determine the amount 
of fenoterol in the plasma sample. For this, blank plasma was spiked with different 
concentrations of fenoterol. Following the same procedures as above, the spiked plasma was 
mixed with ACN for protein precipitation followed by vortex mixing and centrifugation.    
 
 
2.3 Results & Discussions 
 
 
2.3.1 SPME Method Development  
 
 Three commercial prototype coatings, C18, RPA, and CN were selected for evaluation 
[5]. Extractions were performed for 2 minutes using 100 ng/mL at static conditions to determine 
the extraction efficiency. Ten fibres were used for each type of coating for extraction. RPA 
displayed the highest extraction capacity and lowest inter-fibre variability (Figure 9). Therefore, 
it was selected for subsequent in vivo studies.  
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Coatings selection





















Figure 9: Extraction capacity and inter-fibre variability of three types of commercially available 
coating: cyano, C18, and RPA (n=10). Error bars represent one standard deviation 
from the mean. The extraction time was 2 minutes in static condition in 100 ng/mL 
standard PBS buffer solution  
 
 
From previous experiments, it was known that pre-wetting or pre-conditioning the coating 
by soaking the fibres into organic solvent greatly enhanced the extraction efficiency. Therefore, 
two organic solvents, consisting of ACN and MeOH (80:20, v/v) and 100% methanol were 
selected. Extractions were performed in 100 ng/mL after 0, 15, 30, and 60 minutes of pre-
conditioning in desorption solvent. This was compared with extraction performed after 60 
minutes of pre-conditioning in MeOH (Figure 10). It was observed that amount extracted was 
below the limits of quantification (LOQ) when no pre-conditioning was performed on the fibres. 
No difference in extraction efficiency was found after 30 and 60 minutes of pre-conditioning with 
desorption solvent or MeOH. Therefore, on the basis of these results, each RPA probe was pre-




























Figure 10: Effect of pre-conditioning method on amount extracted after the indicated time and 
solvent type (n=3). Error bars represent one standard deviation from the mean. Two 
solvents were selected for pre-conditioning: desorption solvent (DS) and methanol 
(MeOH). The extraction time was 2 minutes in static condition in 100 ng/mL PBS 
buffer standard solution of fenoterol   
 
  
 For SPME method development, it is important to determine the desorption time. The 
selected time should be long enough to allow almost all of the analyte to be desorbed from the 
fibre. In this experiment, extractions were performed in 100 ng/mL fenoterol in PBS buffer for 60 
minutes with vortex (2400 rpm) followed by desorption for 15, 30, 45, and 60 minutes. Carryover 
was determined by subsequent desorption for another 60 minutes in fresh desorption solvent 


























Figure 11: Desorption time determination by extraction with 100 ng/mL fenoterol in PBS buffer 
for 60 minutes with vortex followed by desorption at various time in desorption 
solvent (n=3). Error bars represent one standard deviation from the mean.  
 
A 60 minute desorption time was selected for subsequent experiments as it gave less than 0.5% 
carryover. 
 For pre-equilibrium extraction using the three kinetic calibrations, on-fibre standardization, 
dominant pre-equilibrium desorption, and diffusion-based interface model, the amount extracted 
must be far less than the amount extracted at equilibrium. There are two factors that affect the 
amount extracted: sampling speed and sampling time. Since a syringe or syringe pump would be 
used to push and pull the flowing sample through the interface, this agitation would increase the 
amount extracted by the fibre in comparison with extractions performed at static conditions. 
Therefore, it is important to consider the pump flow rate or the manual push-pull rate by the 
syringe. Because the kinetic calibration methods, specifically the diffusion-based interface model, 
would be applied to sampling real animals such as rats, the sampling rate should be well below 
the normal flow rate in the animal in order to give minimal disturbance. 0.6 mL/min was selected 
based on previous pharmacokinetic studies [6].  
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 To determine the optimal sampling time to use for in vivo study, one must consider both the 
overall sensitivity of the SPME method and temporal resolution when performing 
pharmacokinetic studies. This is because as the extraction time lengthened the sensitivity of the 
SPME method increases because of the increase in the amount extracted by SPME. However, the 
temporal resolution of the pharmacokinetic profile decreases since the concentration measured is 
an average of the extraction time. This factor is especially detrimental to the early time points 
because the concentration changes rapidly immediately after drug administration by i.v. dosing. 
Based on this factor, 2 and 4 minutes were selected for extraction. However, it was discovered 
that the amount extracted at 2 and 4 minutes at the flow rate of 0.6 mL/min was below the 
sufficient amount extracted to observe fenoterol according to previous pharmacokinetic study of 
fenoterol [7]. When the sampling rate was increased to 1.4 mL/min with 4 minutes extraction, the 
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Figure 12: Pump sampling rate versus percent extraction for fenoterol and methoxyfenoterol 
(n=3) and error bars were constructed based on standard deviations. Extractions were 
performed in 100 ng/mL standard whole blood solution.    
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In order to confirm that the amount extracted with flow rate of 1.4 mL/min for 4 minutes was 
below what would be at equilibrium, an extraction time profile in 100 ng/mL standard rat whole 
blood was constructed for both fenoterol and methoxyfenoterol. The extraction was performed at 
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Figure 13: Extraction time profile in rat whole blood for fenoterol and methoxyfenoterol. For 
each time point (n=3), the error bars were constructed based on standard deviations. 
 
 
Based on the extraction time profile, it was confirmed that the amount extracted with 4 minutes 
sampling time was far from the amount extracted at equilibrium thus meeting the requirement for 
kinetics. For in vitro studies, fibres were desorbed right away after extraction. However, for in 
vivo studies using animals, sampling would be performed at NoAb Biodiscoveries Inc. and fibres 
would not be desorbed until hours after extraction. Therefore, stability of the analytes on the fibre 
was important to be determined. From figure 14, both fenoterol and methoxyfenoterol were stable 
on fibres with less than 10% lost after 48 hours of extraction.  
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Figure 14: Stability of fenoterol and methoxyfenoterol on fibres. Extractions were performed 
with vortex (2400 rpm, 60 minutes) at 100 ng/mL standard PBS buffer solution 
followed by desorption after 24, 32, and 48 hours.  
 
 
 The dynamic range for fenoterol and methoxyfenoterol using kinetic SPME and plasma-
protein precipitation was studied. The dynamic range for methoxyfenoterol was determined for 
experiments in chapter 3. Kinetic SPME was performed with the syringe pump at 1.4 mL/min 
with sampling time of 4 minutes and 1 hour for equilibrium extraction. The dynamic range using 
equilibrium extraction was determined only for fenoterol as it was needed for the experiments in 
chapter 2. The regression slope, intercepts, and errors for equilibrium extraction can be found in 


























       
Fenoterol 10-20,000 7 7.1E-3 2.0E-4 2.2E0 1.5E0 0.9986 
Methoxyfenoterol 8-20,000 7 2.1E-2 3.0E-4 9.2E-1 2.9E0 0.9972 





       
Fenoterol 10-20,000 7 4.2E-2 1.2E-3 5.1E-1 1.3E0 0.9958 
Methoxyfenoterol 10-20,000 7 4.6E-2 6.0E-4 -1.5E0 5.8E-1 0.9993 
 
Table 3: A seven point extraction of fenoterol and methoxyfenoterol (n=3) using SPME 
extraction in rat whole blood and plasma protein precipitation. The regression slope 
was obtained from graph of concentration (ng/mL) versus amount extracted (ng) 
 
SPME and conventional plasma protein precipitation methods were compared in terms of 
absolute matrix effects using the same LC-MS method. For  plasma protein precipitation method, 
the relative signal intensity of standard spiked post extraction versus standard prepared directly in 
solvent was 56% and 59% for fenoterol and methoxyfenoterol, respectively. No ionization 
suppression was observed using SPME, as indicated by the relative signal intensities of 95% and 
102% for fenoterol and methoxyfenoterol, respectively.  This illustrates that SPME can provide 
significantly improved sample clean up where it was not achievable with the conventional 
method. For plasma protein precipitation, the slope for fenoterol and methoxyfenoterol was 
greater in comparison with the SPME method. This is because plasma protein precipitation is an 
exhaustive extraction method where SPME only extracts the free analyte. 
 
2.3.2 On-Fibre Standardization 
 For on-fibre standardization, the selection of standard is dependent on the isotropic 
character to the analyte of interest [9-13]. Methoxyfenoterol was initially selected due to its 
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similarity in structure to fenoterol. Previously, Zhou et al. had demonstrated that if the analyte 
and standard were isotropic, the time constant, a, for desorption of the standard, should be similar 
to the time constant of the extraction process of the analyte [14, 15]. Based on this conclusion 
and equations (3) and (4), isotropism can be confirmed either using the ratio of n/ne or Q/q0 for 
both the analyte and standard. If the ratios for analyte and potential standard have similar values, 
their isotropic relationship is positive. This can save much time from determining the extraction 
and desorption time profile for the analyte of interest and standard respectively.  
 
 Fenoterol Methoxyfenoterol 
n (ng) 8.2E-2  1.5E0 
ne (ng) 4.9E0 9.1E0 
n/ne 0.17 0.17 
 
Table 4: Ratio of n/ne for fenoterol and methoxyfenoterol (n=3) 
 
 To obtain q0, the loaded amount of methoxyfenoterol, excess fibres were loaded 
overnight. It is important to load fibres with enough time to achieve equilibrium between the 
loading solution and fibre since the amount loaded would be more consistent. q0 can be 
determined by preloading several extra probes and immediately desorbing them. Two 
concentrations, 10 and 1000 ng/mL were selected for loading (Table 5). For lower concentration 
sample such as 10 ng/mL, fibres were loaded with 10 ng/mL of methoxyfenoterol and for higher 
concentration, 1000 ng/mL of methoxyfenoterol were loaded. This was due to the consideration 
of serial dilution which would be required for higher concentrations before injecting the sample 
into the instrument. If a low concentration was used for loading, the instrument might not be 






Loaded amount of 
methoxyfenoterol on fibre 
(ng) 
              RSD (%) 
                (n = 3)  
10 0.23                    5 
1000 23                    4  
  
 Table 5: The amount of methoxyfenoterol loaded on fibres after overnight extraction with 
agitation (2400 rpm). The loading solution consisted of methoxyfenoterol in 1.5 mL 
PBS buffer 
 
Table 6 displays the results for n, Q, q0 (either 10 or 1000 ng/mL) and the calculated ne by using 
equation 5. Both n and Q were obtained with the same fibre sampling in whole blood and PBS 
buffer with concentration of 10, 5000, and 20,000 ng/mL fenoterol. That is, both extraction and 
desorption were performed simultaneously with 1 fibre. A syringe was used to push and pull the 
sample at a flow rate of 1.4 mL/min through the interface. A syringe pump was not used since a 
control of sampling rate was not required for this calibration method. For actual in vivo 
application of on-fibre standardization, a syringe was used instead of syringe pump. 
 
Table 6: On-fibre standardization- Results for n, Q, q0 which was obtained with fibres (n=3) that 
were not used for extraction, and ne which was calculated with equation 5 
 
 
To calculate the bulk concentration of fenoterol in the sample using ne determined with the aid of 
equation 3, the product of Kfs and Vf was obtained from the slope of calibration plot obtained by 
finding the amount of fenoterol extracted under equilibrium conditions from standard solutions 
containing different amounts of fenoterol (Figure 15).  
 n (ng) (RSD) Q(ng) (RSD) q0(ng) (RSD) ne(ng) (RSD) 






























































































Figure 15: Equilibrium extraction of fenoterol in PBS buffer and blood. The slope of the line 
was used to determine the product of Kfs and Vf. 
 
 
The differences observed in Figure 15 between extraction from whole blood and PBS 
buffer are due to the differences in free concentration of fenoterol in the two matrices. In whole 
blood, fenoterol can bind to biomolecules present, thus lowering the free concentration of analyte 
in solution. The concentration calculated using the slope of the line in figure 15 and equation 2 
can be found in Table 7:  
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  C0 (ng/mL) 
Concentrations Fibre Buffer Blood 
10 (ng/mL) 1 7.7E00 9.0E00 
 2 1.1E00 8.1E00 
 3 9.4E00 1.1E00 
 Mean 9.4E00 9.4E00 
 RSD (%) 19 17 
    
5000 (ng/mL) 1 4.1E03 6.1E03 
 2 5.6E03 4.9E03 
 3 5.9E03 4.6E03 
 Mean 5.2E03 5.2E03 
 RSD (%) 19 15 
    
20000 (ng/mL) 1 1.5E04 2.2E04 
 2 2.1E04 2.1E04 
 3 2.2E04 1.6E04 
 Mean 1.9E04 2.0E04 
 RSD (%) 19 16 
 




2.3.3 Dominant Pre-equilibrium Desorption 
 
 For isotropic desorption, the amount pre-loaded on the fibre must be 4-fold higher than 
the potential extracted amount [14,16]. Therefore, to determine the loading concentration, four 
concentrations of fenoterol, 5000, 10,000, 20,000 and 50,000 ng/mL were selected for loading. 
Similar to on-fibre standardization, fibres were loaded from PBS buffer using equilibrium 
overnight extraction.  
 After deciding the appropriate loading concentration (Figure 16) by comparing amount 
extracted and amount loaded, the loaded fibre was desorbed into the respective sample in order to 


































Figure 16: Amount loaded versus loading concentration of fenoterol (n=3) 
 
Unlike on-fibre standardization, the desorption of the loaded fibre in dominant pre-equilibrium 
desorption was performed separately from extraction. Due to the small surface area of the 
interface, both an extraction and desorption fibre were not able to fit together. Results of n, Q, q0, 
and the calculated ne from equation 3 are displayed in Table 8.  
 
 n (ng) (RSD) Q(ng) (RSD) q0(ng) (RSD) ne(ng) (RSD) 





















































Table 8: Dominant pre-equilibrium desorption- results for n, Q, q0 which was obtained with 
fibres (n=3) that were not used for extraction, and ne which was calculated with equation 
5 
 
The calculated concentration using dominant pre-equilibrium desorption can be found in the 
following table.  
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Concentrations Fibre    Buffer             Blood 
10 (ng/mL) 1 1.5E+01 1.0E+01 
 2 1.3E+01 1.3E+01 
 3 7.9E+00 9.4E+00 
 Mean 1.2E+01 1.1E+01 
 RSD (%) 30 20 
    
5000 (ng/mL) 1 3.7E+03 4.5E+03 
 2 5.1E+03 4.9E+03 
 3 6.5E+03 6.5E+03 
 Mean 5.1E+03 5.3E+03 
 RSD (%) 27 28 
    
20000 (ng/mL) 1 2.3E+04 2.4E+04 
 2 2.2E+04 1.6E+04 
 3 1.5E+04 2.2E+04 
 Mean 2.0E+04 2.1E+04 
 RSD (%) 26 23 
 
Table 9: Concentrations calculated using dominant pre-equilibrium desorption 
 
2.3.4 Diffusion-based Interface Model 
 For diffusion-based interface model calibration [17-21], the calibration constant was 
obtained by extraction of 100 ng/mL of fenoterol standard solution prepared in whole blood and 
PBS buffer, respectively. Using the amount extracted and the known concentration in the sample, 
the calibration constant can be determined using equation (6). In this experiment, five extractions 
were performed to improve the accuracy of the experimental calibration constant with an 







 n (ng) Calibration Constant 
Fibres 
 Buffer Blood Buffer Blood 
1 4.3E-01 3.5E-01 2.3E+02 2.9E+02 
2 5.0E-01 3.6E-01 2.0E+02 2.8E+02 
3 6.4E-01 2.9E-01 1.6E+02 3.4E+02 
4 5.1E-01 2.8E-01 2.0E+02 3.5E+02 
5 5.5E-01 2.9E-01 1.8E+02 3.4E+02 
     
  Mean 1.9E+02 3.2E+02 
  RSD (%) 14 11 
 
Table 10: Determination of experimental calibration constant for buffer and blood using 100 
ng/mL fenoterol (n=5)  
 
The calibrated concentration using the experimental calibration can be found in the following 
table: 
 
 n (ng) Calibrated Concentration (ng/mL) 
Concentrations Buffer Blood Buffer Blood 
10 (ng/mL) 4.6E-02 2.8E-02 8.8E+00 9.0E+00 
 4.9E-02 3.0E-02 9.5E+00 9.6E+00 
 5.9E-02 3.6E-02 1.1E+01 1.2E+01 
                       Mean 9.1E+00 9.3E+00 
                  RSD (%) 15 14 
     
     
5000 (ng/mL) 2.3E+01 1.4E+01 4.5E+03 4.6E+03 
 2.5E+01 1.7E+01 4.9E+03 5.5E+03 
 2.9E+01 1.6E+01 5.6E+03 5.1E+03 
                       Mean 5.0E+03 5.1E+03 
                  RSD (%) 11 9 
     
     
20000 (ng/mL) 1.2E+02 6.3E+01 2.3E+04 2.0E+04 
 1.1E+02 6.9E+01 2.0E+04 2.2E+04 
 1.0E+02 5.7E+01 2.0E+04 1.8E+04 
                       Mean 2.1E+04 2.0E+04 
                  RSD (%) 9 9 
 




The calibration constant can also be determined or verified theoretically by knowing the radius 
and length of the coating, the extraction time, the diffusion coefficient and calculating the 
thickness of boundary layer (7) (Table 12).  The calibration constant can be calculated as follows: 
 




For b, the radius of the fibre was 0.145 mm. The δ was calculated from equation 7. The Reynolds 
number was calculated using Re = ud/ ν, where u, is the linear velocity of the sample, d is the 
diameter of the fibre used, and ν is the kinematic viscosity of the sample matrix. The kinematic 









C [23]. These literature values were used to estimate the calibration 
constant as the kinematic viscosity for blood and PBS buffer at 38
0
C are unavailable to the best 
of author’s knowledge. The Schmidt number was calculated by Sc = ν/ DL, where DL is the 
diffusion coefficient of fenoterol in whole blood and buffer. The diffusion coefficient in both 
media was estimated using parameters from water due to the lack of references available for 




   (9) 
 
where ψ2 is a constant and has the value of 2.6 for water [17], M2 is the molecular weight of 
water, η2 is the viscosity of water and is 0.0423 g/mm•min [17], T is the temperature of the 
experiment, 311.5 K, and v1 is the molar volume of fenoterol and is 309800 mm
3
/mol, calculated 





















                                                                                                          
Fenoterol                                                             Whole Blood                          PBS Buffer 
Experimental (n=5)      320.4 ± 11                           192.6 ± 14                             
Theoretical         304.2*                                      207.1*  
 
Table 13: A comparison between experimental and theoretical calibration constant for fenoterol 
in whole blood and PBS buffer *(The kinematic viscosity of water was taken to be at 
40
0
C and blood at 20
0




From Table 13, the theoretical calibration constant for fenoterol is very close to the range 
of the determined experimental constant for whole blood and PBS. Sample calculation to obtain 
the theoretical constant for fenoterol in blood is illustrated: 
 
  Calibration Constant = 
  b = Radius of fibre coating) = Diameter (mm)/ 2 
              = 290 μm / 2 
              = 0.145 mm 
   
δ = boundary layer      
  Re = Reynolds number = ud 
                                            ν 
u = linear velocity = r/A  
r = sampling rate = 1.4 mL/min = 1400 mm
3
/min 





u = 1400 mm
3
/min       
                                                                      π (1.1mm)
2
 
                                                               = 368.479 mm/min 
 
d = diameter of fibre = 290 mm 




Fenoterol     b  
(mm) 












        DL 
(K•min/mm
2
)   
  L 
(mm) 
   t 
(min) 
Blood 0.145     3.15E-4 0.540      1.05E10     1.89E-8  15    4 









Re = 368.29 mm/min (0.290mm)  
        198 mm
2
/min  
      = 0.540 
Sc = Schmidt number = ν  
   DL 
ν = kinematic viscosity = 198 mm
2
/min  
DL = Diffusion coefficient  
Ψ2 = constant =2.6 for water 
M2 = Molecular weight = 18.0 g/mol for             
water 
T = 311.5 K 
v 1 = molar volume of fenoterol  
     = 17(C) + 21(H) + 1(N) + 4(O) –2 rings 
     = 18(16.5) + 23(2) + 1(5.7) + 4(5.5) –      
2(20.2) 
     = 309.8 cm
3
/mol = 309800 mm
3
/mol 








Sc =    198 mm
2
/min  



















Calibration Constant = 



















































Concentrations Buffer Blood Buffer Blood 
10 (ng/mL) 8.8E+00 9.0E+00 9.4E+00 8.6E+00 
 9.5E+00 9.6E+00 1.0E+01 9.2E+00 
 1.1E+01 1.2E+01 1.2E+01 1.1E+01 
               Mean 9.1E+00 9.3E+00 1.1E+01 9.6E+00 
          RSD (%) 15 14 14 13 
     
     
5000 (ng/mL) 4.5E+03 4.6E+03 4.8E+03 4.4E+03 
 4.9E+03 5.5E+03 5.2E+03 5.2E+03 
 5.6E+03 5.1E+03 6.0E+03 4.9E+03 
              Mean 5.0E+03 5.1E+03 5.4E+03 4.9E+03 
          RSD (%) 11 9 11 9 
     
     
20000 (ng/mL) 2.3E+04 2.0E+04 2.5E+04 1.9E+04 
 2.0E+04 2.2E+04 2.2E+04 2.1E+04 
 2.0E+04 1.8E+04 2.1E+04 1.8E+04 
             Mean 2.1E+04 2.0E+04 2.3E+04 1.9E+04 
        RSD (%) 9 9 9 9 
 
Table 14: Comparison of calibrated concentrations obtained by experimental calibration constant 
and theoretical calibration constant 
 
 
From Table 14, results obtained by using the experimental calibration constant were more 
accurate since the theoretical calibration constants were only estimated. However, the accuracy of 
results predicted using theoretical calibration constant was also very good, indicating the 
usefulness of this method.  
 In addition, for successful application of diffusion-based interface model calibration, two 
requirements must be fulfilled:  the concentration of the analyte in sorbent must be close to zero 
in order for a concentration gradient to be constructed, and a constant agitation or sampling speed 
is required to keep the boundary layer constant. For the first requirement, a prolonged extraction 
time or extraction at equilibrium is detrimental since the sorbent concentration cannot be assumed 
as zero. For the second requirement, because extraction is based on the concentration gradient 
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across the boundary layer, the size of the boundary layer must be kept constant during sampling 
for an accurate calibration. In order to achieve a constant size of boundary layer, the speed of 
agitation must be constant. 
 
2.3.5 SPME Equilibrium Extraction 
 Equilibrium extraction was performed to compare with the three kinetic calibration 
methods. Extractions were performed in whole blood and PBS buffer of 10, 5000, and 20000 
ng/mL fenoterol using the flow-through system The extraction time was 1 hour using a syringe 
pump with flow rate at 1.4 mL/min as this was the extraction time and flow rate to reach 
equilibrium according to figure 13. To determine the initial concentration in the sample, external 
calibration was used. The amount extracted at equilibrium versus concentration was plotted in 
figure 15. The amount extracted ne was calculated using the graph in figure 15 and the following 



















        
Whole Blood 10-21,000 6 1.4E-2 1.8E-3 -2.7E-2 1.5E-2 0.9424 
PBS buffer 10-21,000 6 3.2E-2 2.0E-4 9.7E-2 3.7E-2 0.9841 
  
Table 15: Weighted equation using reciprocal y square for figure 15 
 
The weighted equation was used since the y-intercept of the non-weighted equation was larger 
than the amount extracted at 10 ng/mL. The calculated concentration using equilibrium SPME 
are shown in the following table: 
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 ne (ng)  C0 (ng/mL) 
Concentrations Buffer Blood  Buffer Blood 
10 (ng/mL) 4.4E-01 1.2E-01  1.1E+01 1.1E+01 
 4.2E-01 1.1E-01  9.0E+00 9.7E+00 
 4.4E-01 1.2E-01  1.1E+01 1.0E+01 
   Mean 1.0E+01 1.1E+01 
   RSD(%) 9 9 
      
      
5000 (ng/mL) 1.6E+02 7.6E+01  5.5E+03 5.3E+03 
 1.6E+02 6.4E+01  4.9E+03 4.5E+03 
 1.5E+02 6.9E+01  4.3E+03 4.9E+03 
   Mean 4.9E+03 4.9E+03 
   RSD(%) 12 8 
      
      
20000 (ng/mL) 7.3E+02 2.9E+02  2.3E+04 2.2E+04 
 6.1E+02 2.8E+02  1.9E+04 2.0E+04 
 6.3E+02 2.6E+02  2.0E+04 1.8E+04 
   Mean 2.0E+04 2.0E+04 
   RSD(%) 10 9 
 





2.3.6 Conventional Method-Plasma Protein Precipitation 
 
 Conventional method of plasma protein precipitation was performed to validate the data 
obtained with SPME. To calculate the concentration in the sample using plasma protein 
precipitation, a calibration curve of concentration from 10 – 20,000 ng/mL versus the peak area 
ratio of fenoterol and the internal standard pseudoephedrine was constructed (Figure 17). The 
area ratio obtained from samples of 10, 5,000, and 20,000 ng/mL was substituted into the 
weighted equation from figure 17 to calculate the concentration (Table 17).   
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Figure 17: A plot of peak area ratio of fenoterol and the internal standard versus the concentration 
in the sample. The weighted equation for the line is y=0.1401x + 0.8755 
 
 
 Area Ratio C0 (ng/mL) 
Concentrations   
10 (ng/mL) 2.5E+00 1.1E+01 
 2.4E+00 1.1E+01 
 2.3E+00 9.8E+00 
 Mean 1.1E+01 
 RSD(%) 8 
   
   
5000 (ng/mL) 6.9E+02 4.9E+03 
 7.8E+02 5.6E+03 
 7.0E+02 5.0E+03 
 Mean 5.1E+03 
 RSD(%) 7 
   
   
20000 (ng/mL) 2.8E+03 2.0E+04 
 2.8E+03 2.0E+04 
 3.1E+03 2.2E+04 
 Mean 2.1E+04 
 RSD(%) 7 
 




2.3.7 Calibration Methods Comparison 
 
 
 Relative Recovery (%) 
(RSD, %; n=3) 
Phosphate Saline Solution Buffer 
Concentrations           
(ng/mL) 
 












10 94 (19) 120 (30) 91 (15) 100 (9) 
5,000 104 (19) 102 (27) 100 (11) 98 (12) 
20,000 95 (19) 100 (26) 105 (9) 100 (10) 
 
Table 18: Relative recovery and standard deviation comparison in PBS buffer between 3 in vivo 
calibration methods, equilibrium extraction, and conventional method. For diffusion-
based interface model, the results are based on the experimental calibration constant 





 Relative Recovery (%) 
(RSD, %; n=3) 
Whole Blood 
Concentrations           
(ng/mL) 
 
















10 94 (17) 110 (20) 93 (14) 110 (9) 110 (8) 
5,000 104 (15) 106 (28) 102 (9) 98 (8) 102 (7) 
20,000 100 (16) 105 (23) 100 (9) 100 (9) 105 (7) 
 
Table 19: Relative recovery and standard deviation comparison in whole blood between three in 
vivo calibration methods, equilibrium extraction, and conventional method 
 
 
 Table 18 and 19 compare the three pre-equilibrium SPME calibration methods with 
equilibrium extraction and conventional method. Results obtained between conventional method 
and SPME equilibrium extraction corresponded well with each other which validated the 
compatibility of SPME with the conventional method. Because SPME integrates the sampling 
 49 
procedure and sample preparation, it is a more time effective sampling method: after extraction, 
each fibre was desorbed and the desorption solvent was injected directly into the instrument for 
analysis. The conventional method required many sample preparation steps such as centrifugation 
and vortexing before the sample could be injected into the instrument. PBS buffer is comparable 
to protein-free plasma in terms of matrix effect due to the same ionic strength between the two 
matrices. Musteata et al. had proven that when a drug was spiked into PBS and protein-free 
plasma, the amount extracted was practically the same when using the same type of fibre and 
sampling conditions. In addition, it was found that the pH of the protein-free plasma remained the 
same when isotonic PBS was used to dilute protein-free plasma in a 10:1 ratio [26-27]. 
Therefore, the distribution constant of the fibre and the two matrices was the same due to similar 
ionic strength.  
 When comparing on-fibre standardization and diffusion-based interface model, the 
relative recoveries were very much comparable. However, standard deviation with using on-fibre 
standardization was slightly higher than the diffusion-based interface model. This could be due to 
the extra experimental steps required for loading of fibres prior to sampling for on-fibre 
standardization. The diffusion-based interface model clearly offered an attractive alternative in 
terms of fewer experimental steps and a cost-effective method since the analyte of interest can be 
used as a standard for calibration and fewer fibres are required. In addition, the need for 
additional experiments for calibration step can be eliminated altogether when the calibration 
constant can be calculated. The main disadvantage for the diffusion-based interface model is the 
need to control flow rate or the sampling speed to achieve a constant size of boundary layer. This 
requirement is difficult in certain applications when connection to a pump for controlling of flow 
rate is problematic. However, if sensitivity is not a problem, static extraction can also be 
performed in order to eliminate the need for a pump.   
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 Dominant pre-equilibrium desorption is a new developed technique that has been 
successfully applied to fish muscle by Zhou et al. [16]. Comparing this calibration method with 
the other two pre-equilibrium SPME calibration methods on the same system, this method had 
the highest standard deviation for both whole blood and PBS buffer. Experimental errors were 
incurred from the fibre loading procedures due to variability of fibres even within the same batch. 
In addition to poorer precision, the time required was greater than the other two calibration 
methods. This was because extraction had to be performed first to determine n, and a separate 
experiment was required to determine q0 in order to decide on the loading concentration. In 
addition, it was found by experiment that the sampling speed was also important for dominant 
pre-equilibrium desorption. In order for isotropic relationship to exist between extraction and 
desorption, all experimental parameters including sampling time, sample volume, temperature, 
and sampling speed for the two processes must be the same unless sampling was performed 
under static condition. This was different from on-fibre standardization since the two processes, 







 In this research, three in vivo SPME calibration methods were compared on a flow-
through system. They were evaluated in terms of precision, accuracy and experimental 
procedures, and were validated by equilibrium SPME extraction and a conventional method. All 
three calibration methods had comparable accuracy and the diffusion-based interface model had 
the highest precision. In addition, it did not require any other standard besides the analyte of 
interest and the number of fibres used for calibration was smaller in comparison with the other 
two calibration methods. However, a disadvantage of the diffusion-based interface model was the 
requirement of constant sampling rate and therefore required a pump to perform any extraction. 
In the case where the control of sampling rate is impossible, on-fibre standardization, which had a 
comparable accuracy as diffusion-based interface model, may be the next best alternative. Since 
desorption and extraction occurred simultaneously on one fibre, desorption was used to calibrate 
extraction. Dominant pre-equilibrium desorption has the same calibration principle as on-fibre 
standardization, however, it had the lowest precision. This could be due to the excessive number 
of fibre required which increased both error and cost. Since the sampling area, or the interface, 
was too small to fit both an extraction and a desorption fibre, two separate experiments were 
performed for extraction and desorption. This required more time and further reduced the 
precision of the results in comparison to on-fibre standardization. Therefore, based on this 
research, diffusion-based interface model had the most favorable results with the least 
experimental procedures. This clearly suggests potential use of diffusion-based interface model 
for future in vivo SPME studies.          
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 Chapter 3: Pharmacokinetic studies of fenoterol and methoxyfenoterol in rats using semi-
automated in vivo solid-phase microextraction sampling and diffusion-based interface 





 SPME can be used to sample circulating blood of animals without the need to withdraw a 
representative blood sample. In this study, in vivo SPME in combination with liquid-
chromatography tandem mass spectrometry was used for pharmacokinetic studies of two drug 
analytes: fenoterol and methoxyfenoterol on five rats. This research illustrates, for the first time, 
the feasibility of a diffusion-based interface model calibration for in vivo SPME studies. To 
provide a constant sampling rate as required for the diffusion-based interface model, partial 
automation of SPME animal sampling was accomplished using Accusampler®, an instrument 
capable of automated repetitive blood sampling from rats. The use of the Accusampler® with a 
custom-written program allowed the automation of all in vivo SPME steps except the insertion 
and removal of the SPME probe.  Each semi-automated in vivo SPME sampling was followed by 
automatic blood draw in order to enable the comparison of SPME results to traditional analysis 
based on blood withdrawal and plasma-protein precipitation. The results obtained show good 
agreement between SPME and the conventional method, indicating the utility of the proposed 
method. In addition, in vivo SPME allowed the monitoring of the metabolite methoxyfenoterol 
glucuronide, which could not be detected using the traditional plasma protein precipitation 
method. The proposed diffusion-based interface model has several advantages over other kinetic 
calibration models for in vivo sampling including: (i) It does not  require any addition of standard 
into the sample matrix during in vivo studies, (ii) it is simple, rapid and eliminates the need to 
pre-load appropriate standard into SPME extraction phase and (iii) the calibration constant can be 
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calculated based on the diffusion coefficient, extraction time, fibre length and radius, and size of 





 showed excellent agreement with the theoretical calibration constants of 
304.2 mm
-3
 and 315.3 mm
-3




 Asthma, a chronic inflammatory disease of the airways, is a growing public concern since 
it is one of the most prevalent chronic diseases with more than 100 million sufferers worldwide 
according to statistics from Asthma Society of Canada [1]. Consequently, much effort and 
resources are put into research of asthma medications each year in the hope of discovering new 
active compounds to target the disease.    
 Fenoterol, 5-[1-hydroxy-2-[[2-(4-hydroxyphenyl)-1-methylethyl]-amino]ethyl]-1,3-
benzenediol, is a β2-adrenoceptor (β2-AR) agonist that is used for the treatment of asthma and 
congestive heart failure [2-3]. The prescriptive fenoterol is a racemic mixture of (R,R)-fenoterol 
and (S,S)-fenoterol. However, previous preclinical studies, cellular membrane affinity 
chromatography studies and cardiomyocyte binding and contraction assays, conducted by 
Wainer’s group at National Institute of Health (NIH), have demonstrated that (S,S)-fenoterol is 
essentially inactive at the receptor while (R,R)-fenoterol is responsible for the β2-AR agonist 
activity [3]. Additionally, the data from these studies have shown that (R,R)-methoxyfenoterol, a 
fenoterol derivative, has the same activity as (R,R)-fenoterol at the β2-AR. Thus, it was proposed 
that (R,R)-methoxyfenoterol could also be used as asthma and heart failure medication. In this 
research, a comparative pharmacokinetic study of (R,R)-fenoterol and (R,R)-methoxyfenoterol 
was conducted.  
 In designing a preclinical study, the sensitivity of the bioanalytical assay is a primary 
concern. This is especially true with low bioavailability drugs such as fenoterol, with an 
incomplete absorption and extensive metabolism via phase II pathways [2, 4]. Therefore, the 
success of the study is greatly dependent on method selection. The first pharmacokinetic study of 
fenoterol on rats was performed by Koster et al. where fenoterol was extracted by ion-pair 
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extraction into ethyl acetate using BIS as a pairing agent after various routes of administration 
[4]. Recently, Siluk et al. performed plasma-concentration time analysis on fenoterol using solid 
phase extraction (SPE) [2], and Kim et al. developed an online immunoextraction method for 
better sensitivity and specificity extraction of fenoterol [5]. However, all these methods measured 
the drug concentration in plasma samples which require collection of blood samples of at least 
0.150 mL [5] and further processed to plasma.  
 Since the invention of SPME, a novel sampling technique, in vivo studies such as drug 
dosing and pharmacokinetics have been made simpler with the integration of sampling and 
sample preparation [6]. SPME allows direct extraction of a drug circulating in animal blood 
without the need to withdraw any blood sample. This eliminates the need to separate plasma from 
whole blood, speeds up overall sample preparation time and minimizes inadvertent analyte losses 
during sample preparation because the number of sample handling steps is greatly reduced.  Most 
importantly, SPME allows the monitoring of free or unbound concentrations of drug analyte 
where most conventional methods offer the total concentrations [7-8]. Measurement of free 
concentration is important as it is the unbound drug analyte that determines its efficacy. 
 The main objective of this research was to apply the diffusion-based interface calibration 
model for the first time to in vivo SPME pharmacokinetic studies in rats. However, initial 
pharmacokinetic studies performed on rats using in vivo SPME relied on a polyurethane interface 
connected to the carotid artery catheter and manual assisted agitation using push-pull method 
with a syringe [9]. This type of manual sampling would not provide sufficiently uniform agitation 
to enable the use of diffusion-based interface calibration, so in current research the process of in 
vivo SPME sampling was  further automated using AccuSampler®, a commercial instrument 
automated for repetitive blood sampling,  The automated system allowed for a much easier 
sampling procedure, minimal animal contact, and  provided uniform and reproducible flow rates 
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within the tubing which permitted the use of diffusion-based interface calibration model for in 
vivo SPME studies for the first time. The model was successfully applied to comparative 
pharmacokinetic study of fenoterol and methoxyfenoterol on five rats. In addition, a conventional 
method based on blood withdrawal was performed to validate the SPME data obtained.  
 
3.3 Materials and methods 
 
3.3.1 Materials 
 (R,R)-Fenoterol and (R,R)-methoxyfenoterol were obtained from National Institute of 
Health (Baltimore, MD, US). Pseudoephedrine and ammonium acetate were purchased from 
Sigma-Aldrich (St. Louis, MO, US). The standards were diluted to different concentrations either 
in methanol for instrument calibration or PBS pH 7.4, for in vitro experiments. HPLC grade 
acetonitrile and methanol were purchased from Fisher Scientific (Fair Lawn, NJ, US). Fresh rat 
whole blood (sodium heparin as anticoagulant) and plasma were obtained from NoAb 
BioDiscoveries Inc. (Mississauga, ON, Canada). Rat whole blood was maintained at 4
0
C for 
maximum 1 week and plasma was kept frozen at -20
0
C until use. Deionized water was obtained 
from a Barnstead/Thermodyne Nano-pure ultrapure water system (Dubuque, IA, US).      
 
3.3.2 LC-MS/MS Assay- Please see section 2.2.2 
 






3.3.4 Animal Experiments 
 
 Ten conscious Sprague-Dawley rats (Charles River Labs, St. Constant, PQ, Canada) 
weighing approximately 300 g were used to conduct in vivo experiments: five rats for fenoterol 
and five for methoxyfenoterol. Animals were conscious and freely moving throughout the study.  
  The catheter from the animal was linked to the AccuSampler® tubing system (Dilab, 
Lund, Sweden). Rats were administered 5 mg/kg of either fenoterol or methoxyfenoterol. At each 
time point, a pre-conditioned, sterile SPME device was inserted by piercing the septum of the 
interface and only the coated portion of the wire housed inside the hypodermic needle was 
exposed to the flowing blood. The flow rate of the pump was 1.4 mL/min which was well below 
normal blood flow rate in the rat carotid artery for minimal disturbance. The push-pull volume 
was 0.35 mL. After sampling, the blood was returned to the animal and the catheter was flushed 
with saline to compensate for the lost blood to maintain fluid balance within the animal. For each 
time point, two samplings were performed: SPME sampling was performed first followed by 
blood withdrawal of 0.2 mL for conventional plasma analysis 
 
3.3.5 In Vivo SPME Procedure 
 Before drug administration, a zero time probe analysis was performed followed by blood 
draw (0.2 mL). Drug concentration was monitored for 6 hours at time points 3, 15, 30, 60, 120, 
180, 240, 300, and 360 minutes. After 4 minutes of extraction, the probe was removed from the 
interface and quickly rinsed with water to prevent blood clotting at the tip of the hypodermic 
needle. Residual water on the fibre was blotted lightly with a Kimwipe tissue. The SPME probes 
were stored at -20
0
C until analysis was performed. A new fibre was used for each time point.         
The probes collected were desorbed in 0.1 mL inserts with desorption solvent for 1 hour 
with vortex (2400 rpm).  A 0.01 mL portion of pseudoephedrine (50 ng/mL) was added and the 
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resulting solution was vortexed manually. A 0.02 mL portion was injected for analysis using the 
chromatographic conditions as stated in section 2.2.2. 
 
 
3.3.6 Conventional Plasma Sampling and Analysis 
 
 For validation purposes, 0.2 mL blood was withdrawn after SPME sampling. The time 
points when blood draws were performed were 7, 19, 34, 64, 124, 184, 244, 304, 364 min.  The 
blood sample was subsequently centrifuged (6700 rpm, 5 min, 4
0
C) and plasma was isolated and 
frozen at -20
0
C in 2 mL cryovials (Wheaton Science Products, Millville, NJ, US) until analysis. 
For analysis, protein precipitation was first performed. 0.08 mL of plasma was mixed with 0.30 
mL of HPLC grade acetonitrile in conical centrifuge vials. After vortex mixing (2400 rpm, 5 
min) and centrifugation (14,000 rpm, 10 min, 4
0
C), 0.01 mL of the supernatant was transferred to 
a 0.1 mL insert (Supelco, Bellefonte, PA, US) followed by an addition of 0.09 mL of desorption 
solvent for dilution and 0.01 mL of pseudoephedrine (50 ng/mL) as internal standard to control 
for injection volume variation. The resulting solution was vortexed manually and 0.02 mL was 
injected for analysis using the chromatographic conditions as stated in section 2.2.2.  
 
3.3.7 Calibration Methods 
For diffusion-based interface model calibration, the diffusion constant was determined 
using 100 ng/mL of 10 mL whole blood sample (n=5 determinations). The blood sample was 
incubated at 37
0
C and sampling was performed with the AccuSampler® pump using the same 
sampling parameters as the in vivo studies on the animals.  The determined diffusion-based 




3.4 Results and Discussions 
 
 
3.4.1 Calibration Method - Diffusion-based Interface Model 
 
 For the diffusion-based interface model, the calibration constant was obtained by 
performing SPME procedure in rat whole blood spiked with known amount of fenoterol or 
methoxyfenoterol. To mimic the actual in vivo experiment, 10 mL whole blood of 100 ng/mL 
fenoterol or methoxyfenoterol was incubated at 37
0
C and all other sampling parameters i.e. 
sampling rate and extraction time remained the same. Using the amount extracted and the known 
concentration in the sample, the calibration constant can be determined. Extractions were 
performed five times to obtain a better precision.  
 The theoretical calibration constant was determined similar to section 2.3.4. 
 
Table 20: Parameters used to calculate calibration constant for fenoterol and methoxyfenoterol. 
Sc= ν/DL, where ν is the kinematic viscosity of water, and Re = ud/ν, where u is the 
linear velocity of the sample and d is diameter of the fibre used. 
 
 The radius of the fibre was 0.145 mm. All parameters, including the kinematic viscosity 
of blood, sampling time, and temperatures, were the same as section 2.3.4.  The molar volume to 
calculate the diffusion coefficient was calculated by summing the size of the atoms making up the 
chemical’s structure [10]. For fenoterol, the molar volume is 309800 mm
3
/mol and 330300 
mm
3
/mol for methoxyfenoterol. 
 
 
     b  
(mm) 












        DL 
(K•min/mm
2
)   
  L 
(mm) 
   t 
(min) 
Fenoterol 0.145 3.15E-4 0.540 1.05E10 1.89E-8  15    4 
Methoxyfenoterol 0.145 3.14E-4 0.540 1.09E10 1.82E-8  15    4 
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          Experimental  
               (n = 5) 
               (mm
-3
) 




Fenoterol                338.9 ± 30                 304.2                                       
Methoxyfenoterol                298.5 ± 25                 315.3 
 
Table 21: A comparison between experimental and theoretical calibration constant for fenoterol 
and methoxyfenoterol  
 
Similar to the diffusion-based interface model calibration performed in chapter 2, the theoretical 
calibration constant for both fenoterol and methoxyfenoterol is either within or very close to the 
range of the determined experimental constant.  
In terms of the calibration method, the diffusion-based interface model is convenient as it 
does not require any addition of standard. If literature values can be accessed easily, the 
calibration constant can be calculated and the calibration step can be omitted altogether. In the 
case where the values for the parameters can only be estimated, as in the case for fenoterol and 
methoxyfenoterol since these analytes are not well researched, a calibration constant obtained 
experimentally may be more accurate. Nevertheless, the calibration method for the diffusion-
based interface model is simple and therefore offers an attractive alternative to other previously 
used pre-equilibrium calibration methods 
 
3.3.2 Pharmacokinetic Profiles  
The sampling procedures employed for in vivo SPME were much simpler compared to 
previous pharmacokinetic studies on rats [9]. Since the interface was connected to the 
Accusampler® instead of on the nape of the animal’s neck, direct handling of the animal during 
sampling was avoided. In addition, during the sampling time of 4 minutes, the animal was 
allowed to move freely in the cage where as in the previous pharmacokinetic studies, the animal 
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was held by the analyst during the time of extraction (Figure 18). This causes extra stress on the 
animal during the experiment and might have possible effect on the accuracy of the results. 
  
Figure 18: Connection of Accusampler ® with a rat [11] 
 
The fenoterol (Figure 21) and methoxyfenoterol (Figure 22) concentration versus time profiles 
obtained by SPME sampling which measured the concentrations in whole blood were validated 
by conventional method, protein precipitation, which measured the analyte concentrations in 
plasma. The distribution of fenoterol and methoxyfenoterol are different in plasma and whole 
blood. Therefore, the results from plasma and whole blood cannot be compared directly for drugs 
whose red blood cell (RBC) to plasma partition ratio is different from 1. In current study, the 
RBC to plasma partition ratio was determined for fenoterol and methoxyfenoterol using SPME. 
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Extractions were performed in SPME and plasma sample spanning the circulated concentration 
for fenoterol and methoxyfenoterol. The RBC-plasma partition ratio was determined by the ratio 
of the slope plotted with concentration against the amount extracted (Figure 19, 20).  
 
Methoxyfenoterol- Blood to plasma ratio




































Figure 19: Determination of blood to plasma ratio of methoxyfenoterol using the slope of 
concentration versus amount extracted  
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Fenoterol- Blood to plasma ratio



































Figure 20: Determination of blood to plasma ratio of fenoterol using the slope of concentration 
versus amount extracted  
 
 
From this experiment, the conversion factor of 1.7 and 2.1 for fenoterol and methoxyfenoterol 
was determined and applied to the plasma sample. Koster et al. also determined the RBC-plasma 
partition ratio to be 1.76±0.10 [4], which further validated the SPME method to determine the 










































Figure 21:  Mean concentration versus time profiles of fenoterol in logarithmic scale (n =5) 
following 5 mg/kg i.v. administration. (•) represents data points obtained by SPME 
and (■) represents data points obtained by conventional method. Plasma data was 
corrected for RBC-plasma partition ratio of 1.7 to facilitate the comparison of two 



















































Figure 22:  Mean concentration versus time profiles of methoxyfenoterol (n =5) in logarithmic 
scale following 5 mg/kg i.v. administration. (•) represents data points obtained by 
SPME and (■) represents data points obtained by conventional method. Plasma data 
was corrected for RBC-plasma partition ratio of 2.1 to facilitate the comparison of 
two methods. Diffusion-based calibration was used to calibrate results obtained by 
SPME.  
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 The pharmacokinetic profiles of both analytes show a good correlation between the 
concentrations obtained by SPME method and conventional method except for the earlier time 
points where the concentrations measured by SPME were higher than concentrations measured 
by conventional method. This could be explained by the rapid concentration changes following 
drug administration, the fact that SPME sampling was performed over a 4-min period and the 
time difference between SPME sampling and blood withdrawals; for the conventional method, 
blood was withdrawn 4 minutes following SPME. As time increased, the concentration change 
became less dramatic, and therefore, the measured concentrations between the two sampling 
methods showed much better correlation at later time points. Siluk et al. also performed 
pharmacokinetic study on fenoterol [2]. The profiles obtained displayed similar pattern as was 
obtained using SPME.  
 In addition to measuring the concentrations of the administered analytes, the metabolites 
of both fenoterol and methoxyfenoterol were monitored simultaneously. Fenoterol glucuronide 
was not detected with SPME and conventional sampling but methoxyfenoterol glucuronide was 
detected only with SPME (Figure 23). This further illustrates the sensitivity of the SPME method. 
Due to the lack of methoxyfenoterol glucuronide standard, the exact concentrations of the 
detected metabolite could not be determined at this time. However, this is the first report of the 
use of in vivo SPME to sample very polar metabolites such as glucuronides thus further 














































Figure 23: Detection of methoxyfenoterol glucuronide (n=2) simultaneously with 
methoxyfenoterol.  The presence of methoxyfenoterol glucuronide was only detected 







 Diffusion-based interface model calibration and the use of an automated SPME blood 
sampler, AccuSampler®, were successfully applied for the first time to in vivo SPME. Use of the 
AccuSampler® simplified the extraction procedures and minimized direct contact with the 
animal during the experiment. In addition, it provided a constant blood flow into the interface for 
extraction, a requirement for diffusion-based interface model calibration. Diffusion-based 
interface model calibration, unlike previously used kinetic calibration, does not require any other 
deuterated or radioactive compounds as standards and does not require any pre-loading steps 
prior to in vivo experiments. The calibration constant can be estimated using theoretical 
calculations and parameters obtained from literature or can simply be determined by extraction 
with a known concentration sample and using the same sampling parameters as the actual in vivo 
experiments. Therefore, this calibration approach not only extends the applicability of pre-
equilibrium in vivo SPME to situations where no appropriate standard is available, but also 
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